Shanxi C&Y Pharmaceutical Co.,Ltd. Posted 98 Million Yuan Net Loss in 2022

Shanxi C&Y Pharmaceutical Co.,Ltd. (山西仟源医药集团股份有限公司) (300254.SZ) reported a net loss of 98 million yuan in 2022, widening 31.4% year-on-year.

Meanwhile, the company posted 829 million yuan in revenue, down 10.9% year-on-year.

At the end of the reporting period, it had 1.6 billion yuan in total assets and 854.6 million yuan in total liabilities, with a liability-to-asset ratio of 53.9%.